These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A. Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994 [Abstract] [Full Text] [Related]
3. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Lu Q, Luo R, Bodin L, Yang J, Zahr N, Aubry A, Golmard JL, Rouby JJ, Nebulized Antibiotics Study Group. Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092 [Abstract] [Full Text] [Related]
5. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review. Celik IH, Oguz SS, Demirel G, Erdeve O, Dilmen U. Eur J Pediatr; 2012 Feb; 171(2):311-6. PubMed ID: 21809011 [Abstract] [Full Text] [Related]
6. Inhaled colistin for lower respiratory tract infections. Antoniu SA, Cojocaru I. Expert Opin Drug Deliv; 2012 Mar; 9(3):333-42. PubMed ID: 22332963 [Abstract] [Full Text] [Related]
7. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V. Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803 [Abstract] [Full Text] [Related]
9. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA. Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485 [Abstract] [Full Text] [Related]
10. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii]. Taşbakan MS, Pullukçu H, Ekren PK, Oz AT, Midilli M, Aydemir S, Gürgün A, Başoğlu OK, Bacakoğlu F. Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381 [Abstract] [Full Text] [Related]
12. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. Lin CC, Liu TC, Kuo CF, Liu CP, Lee CM. J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293 [Abstract] [Full Text] [Related]
15. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit. Timofte D, Dan M, Maciuca IE, Ciucu L, Dabija ER, Guguianu E, Panzaru CV. Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064 [Abstract] [Full Text] [Related]
19. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. Luque S, Escaño C, Sorli L, Li J, Campillo N, Horcajada JP, Salas E, Grau S. Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275 [Abstract] [Full Text] [Related]